Global Nerve Monitoring System Market Size study & forecast, by Technology (Electromyography (EMG), Electroencephalography (EEG), Electrocorticography (ECOG), Evoked Potential (EP)) by Application (Neurosurgery, Spine Surgery, ENT Surgery, Cardiovascular

Global Nerve Monitoring System Market Size study & forecast, by Technology (Electromyography (EMG), Electroencephalography (EEG), Electrocorticography (ECOG), Evoked Potential (EP)) by Application (Neurosurgery, Spine Surgery, ENT Surgery, Cardiovascular Applications, Other Applications), by End User (Hospitals and Surgical Centers, Ambulatory Surgical Centers) and Regional Analysis, 2022-2029

Global Nerve Monitoring System Market is valued approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Nerve monitoring systems are medical devices that are used during surgery to monitor the integrity and function of nerves. These systems work by detecting and measuring the electrical signals that are transmitted by nerves during surgery. During certain surgical procedures, such as those that involve the removal or manipulation of tumors, nerves can be inadvertently damaged, which can lead to permanent loss of function or paralysis. Nerve monitoring systems are designed to help prevent such damage by providing real-time feedback to the surgeon about the location and function of nerves in the area being operated on. The key factor driving the market growth is growing use of nerve monitoring in trauma cases, rising availability of medical reimbursements for nerve monitoring, and clinical benefits associated with nerve monitoring procedures is anticipated to support the market growth during forecast period.

However, the rising continues development by market players in nerve monitoring system is anticipated to influence the market growth. For instance, in April 2022, the level 1 FREEDOM clinical trial series was started by Stimwave Technologies. Peripheral nerve stimulation (PNS) responses in patients with chronic pain are monitored over the course of time in the FREEDOM clinical trial series, which comprises of multi-center, prospective, randomized clinical trials. Additionally, increased clinical studies in the field of nerve monitoring and rising investment in research and development in nerve monitoring system is projected to create the lucrative opportunity for the market during forecast period. However, the limited awareness about nerve monitoring among healthcare professionals’ stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Nerve Monitoring System Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to the clinical benefits associated with nerve monitoring procedures and the growing use of nerve monitoring in trauma cases. In addition, increasing product launches in the region. Whereas, Asia Pacific is also anticipated to exhibit highest growth rate over the forecast period, owing to factors such as increase in surgical procedures, growing research and development activities and cohesive government initiative in the region would create lucrative growth prospects for the Nerve Monitoring System market across Asia Pacific region.

Major market player included in this report are:
Medtronic (Ireland)
NuVasive (US)
Nihon Kohden (Japan)
Bovie Medical (US)
Natus Medical (US)
Checkpoint Surgical (US)
Magstim (UK)
Inomed (Germany)
Erbe Elektromedizin (Germany)
Dr. Langer Medical (Germany)

Recent Developments in the Market:
In Feb. 2022, InterStim X, a personalized device to administer sacral neuromodulation (SNM) therapy, was granted the thumbs-up by the US Food and Drug Administration (FDA).
Global Nerve Monitoring System Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Technology, Application, End User, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Technology:
Electromyography (EMG)
Electroencephalography (EEG)
Electrocorticography (ECOG)
Evoked Potential (EP)
By Application:
Neurosurgery
Spine Surgery
ENT Surgery
Cardiovascular Applications
Other Applications
By End User:
Hospitals and Surgical Centers
Ambulatory Surgical Centers
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Companies Mentioned

Medtronic (Ireland)
NuVasive (US)
Nihon Kohden (Japan)
Bovie Medical (US)
Natus Medical (US)
Checkpoint Surgical (US)
Magstim (UK)
Inomed (Germany)
Erbe Elektromedizin (Germany)
Dr. Langer Medical (Germany)

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.